Nathan Caffo

Corporate Officer/Principal en CANDEL THERAPEUTICS, INC. .

55 años

Health Technology

Consumer Services

Perfil

Nathan Caffo is a professional who has worked in the biotech industry.
He is currently the Chief Business Officer at Candel Therapeutics, Inc. He previously worked as the President & Chief Executive Officer at Presage Biosciences, Inc. from 2009 to 2018, and as the Chief Business Officer at ALX Oncology Holdings, Inc. from 2018 to 2020.
Mr. Caffo received his undergraduate degree from The Pennsylvania State University.

Cargos activos de Nathan Caffo

Empresas	Cargo	Inicio
CANDEL THERAPEUTICS, INC.	Corporate Officer/Principal	01/09/2020

Todos los cargos activos de Nathan Caffo

Antiguos cargos conocidos de Nathan Caffo.

Empresas	Cargo	Fin
ALX ONCOLOGY HOLDINGS INC.	Corporate Officer/Principal	01/09/2020
Presage Biosciences, Inc. Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Presage Biosciences, Inc. engages in development of novel drugs for treatment of cancers. It offers CIVO arrayed microinjection platform that allows for simultaneous assessment of multiple drugs or drug combinations directly in a single solid tumor while still in a patient’s body to assess efficacy, resistance, and drug synergies in the tumor’s native microenvironment. The company was founded by James M. Olson and Thane Kreiner in 2008 and is headquartered in Seattle, WA.	Chief Executive Officer	17/07/2018

Ver el detalle de la experiencia de Nathan Caffo.

Formación de Nathan Caffo.

The Pennsylvania State University

Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Nathan Caffo.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	2
CANDEL THERAPEUTICS, INC.	Health Technology
ALX ONCOLOGY HOLDINGS INC.	Health Technology

Empresas privadas	1
Presage Biosciences, Inc. Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Presage Biosciences, Inc. engages in development of novel drugs for treatment of cancers. It offers CIVO arrayed microinjection platform that allows for simultaneous assessment of multiple drugs or drug combinations directly in a single solid tumor while still in a patient’s body to assess efficacy, resistance, and drug synergies in the tumor’s native microenvironment. The company was founded by James M. Olson and Thane Kreiner in 2008 and is headquartered in Seattle, WA.	Health Technology